Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02614560
What this trial is testing

Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

Who this might be right for
Acute Myeloid Leukemia
Seagen Inc. 14
Large-scale testing (Phase 3)UnknownNCT00003924
What this trial is testing

Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Study Association 360
Testing effectiveness (Phase 2)Looking for participantsNCT04784052
What this trial is testing

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Who this might be right for
Fanconi Anemia
Porteus, Matthew, MD 18
Testing effectiveness (Phase 2)UnknownNCT02752243
What this trial is testing

CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.

Who this might be right for
Myelodysplastic SyndromesAcute Leukemia
Peter Bader 32
Testing effectiveness (Phase 2)Study completedNCT00731328
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesNonmalignant Neoplasm+1 more
Asan Medical Center 15
Very early researchNot Yet RecruitingNCT07674199
What this trial is testing

EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT

Who this might be right for
Patients After Hematopoietic Stem Cell Transplantation
The General Hospital of Western Theater Command 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05126186
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure

Who this might be right for
Hematologic DiseasesGraft FailureAllogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 35
Post-approval studies (Phase 4)UnknownNCT02905942
What this trial is testing

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Lymphoma
Peking University 96
Not applicableStudy completedNCT00462878
What this trial is testing

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

Who this might be right for
Allogenic Blood Stem Cell TransplantationFebrile Neutropenia
PETHEMA Foundation 392
Testing effectiveness (Phase 2)Looking for participantsNCT07101497
What this trial is testing

Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia

Who this might be right for
Menin InhibitorsPost Hematopoietic Stem Cell TransplantationMaintenance Therapy+4 more
The First Affiliated Hospital of Soochow University 60
Early research (Phase 1)Study completedNCT00003243
What this trial is testing

Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Not applicableUnknownNCT06148610
What this trial is testing

Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support

Who this might be right for
Hematologic DiseasesBone Marrow TransplantationHematopoietic Stem Cell Transplantation
Fonds de Dotation HTC Project 170
Testing effectiveness (Phase 2)Study completedNCT00153985
What this trial is testing

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseThalassemia
Dana-Farber Cancer Institute 2
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Early research (Phase 1)Ended earlyNCT05065047
What this trial is testing

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT01582048
What this trial is testing

Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Patients Receiving Mismatched Allogeneic HCT
Prof. Dr. med. Wolfgang Bethge 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05317416
What this trial is testing

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Who this might be right for
Multiple Myeloma
Pfizer 854
Testing effectiveness (Phase 2)Study completedNCT04269811
What this trial is testing

Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

Who this might be right for
Relapse Rate After Allo-HSCT
Shanghai Jiao Tong University School of Medicine 49
Next Page